Assesment of saliva and gingival crevicular fluid Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Galectin-1 and TNF-α (Tumor Necrosis Factor Alpha) levels in individuals with different periodontal diseases
Phase 1
Completed
- Conditions
- Chronic periodontitis,GingivitisSuPAR,Galectinǃ,TNF α,
- Registration Number
- TCTR20180808003
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Systemic healthy, non smoker, those who had not take antibiotic/anti-inflammatory drugs,each half quadrant has at least two permanent teeth
Exclusion Criteria
Individuals with medical disorders such as diabetes mellitus, immunologic disorders, pregnant or nursing females, smokers and those who had antibiotic/anti-inflammatory drugs or periodontal therapy in the previous 6 months were excluded from the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion of clinical measurements 3 months after first volunteer recruited Probing depth, Clinical attachment level,Bleeding on probing, Gingivai index, Plaque index
- Secondary Outcome Measures
Name Time Method Complete analysing of biochemical samples 1 month after clinical measurements are completed Enzyme-Linked Immunosorbent Assay